Experience with Luspatercept in SF3B1-mutant Myelodysplastic Syndromes
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic disorders marked by ineffective hematopoiesis and cytopenias. SF3B1-mutated MDS, now classified as MDS with low blasts and SF3B1 mutation (MDS-SF3B1) in the 2025 World Health Organization update, represents a distinct...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Wolters Kluwer Medknow Publications
2026-01-01
|
| coleção: | Archives of Medicine and Health Sciences |
| Assuntos: | |
| Acesso em linha: | https://journals.lww.com/10.4103/amhs.amhs_315_25 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|